Martingale Asset Management L P Ani Pharmaceuticals Inc Transaction History

Martingale Asset Management L P

$4.02 Billion
Q2 2025

A detailed history of Martingale Asset Management L P transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Martingale Asset Management L P holds 24,114 shares of ANIP stock, worth $2.29 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

24,114

Previous 23,615 2.11%

Holding current value

$2.29 Million

Previous $1.58 Million 0.51%

% of portfolio

0.04%

Previous 0.04%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$57.79 - $72.95 $28,837 - $36,402	499 Added 2.11%	24,114 $1.57 Million
Q1 2025 May 14, 2025	SELL	$53.93 - $68.36 $138,168 - $175,138	-2,562 Reduced 9.79%	23,615 $1.58 Million
Q4 2024 Feb 13, 2025	SELL	$53.35 - $61.74 $456,836 - $528,679	-8,563 Reduced 24.65%	26,177 $1.45 Million
Q3 2024 Nov 14, 2024	BUY	$54.33 - $65.72 $745,353 - $901,612	13,719 Added 65.26%	34,740 $2.07 Million
Q2 2024 Aug 12, 2024	BUY	$58.53 - $68.82 $151,592 - $178,243	2,590 Added 14.05%	21,021 $1.34 Million
Q1 2024 May 14, 2024	BUY	$54.2 - $69.69 $76,476 - $98,332	1,411 Added 8.29%	18,431 $1.27 Million
Q3 2023 Nov 14, 2023	SELL	$50.28 - $64.61 $50 - $64	-1 Reduced 0.01%	17,020 $988,000
Q2 2023 Aug 11, 2023	BUY	$37.29 - $53.83 $29,832 - $43,064	800 Added 4.93%	17,021 $916,000
Q4 2022 Feb 13, 2023	BUY	$31.9 - $41.95 $9,410 - $12,375	295 Added 1.85%	16,221 $652,000
Q3 2022 Nov 14, 2022	BUY	$29.83 - $38.01 $92,473 - $117,831	3,100 Added 24.17%	15,926 $513,000
Q2 2022 Aug 11, 2022	BUY	$23.09 - $33.46 $58,117 - $84,218	2,517 Added 24.42%	12,826 $380,000
Q1 2022 May 12, 2022	BUY	$26.91 - $47.15 $21,554 - $37,767	801 Added 8.42%	10,309 $289,000
Q4 2021 Feb 11, 2022	BUY	$32.97 - $56.85 $313,478 - $540,529	9,508 New	9,508 $438,000
Q4 2020 Feb 10, 2021	SELL	$23.69 - $31.47 $564,035 - $749,269	-23,809 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$26.38 - $33.1 $704,346 - $883,770	-26,700 Reduced 52.86%	23,809 $671,000
Q2 2020 Aug 10, 2020	SELL	$29.93 - $50.1 $119 - $200	-4 Reduced 0.01%	50,509 $1.63 Million
Q1 2020 May 11, 2020	BUY	$30.35 - $67.14 $312,635 - $691,609	10,301 Added 25.62%	50,513 $2.06 Million
Q4 2019 Feb 10, 2020	SELL	$55.65 - $79.83 $300,510 - $431,082	-5,400 Reduced 11.84%	40,212 $2.48 Million
Q3 2019 Nov 13, 2019	BUY	$64.7 - $85.39 $194,164 - $256,255	3,001 Added 7.04%	45,612 $3.32 Million
Q2 2019 Aug 13, 2019	BUY	$67.77 - $82.2 $1.05 Million - $1.27 Million	15,502 Added 57.18%	42,611 $0
Q1 2019 May 08, 2019	BUY	$45.83 - $70.54 $174,154 - $268,052	3,800 Added 16.3%	27,109 $0
Q4 2018 Feb 11, 2019	BUY	$41.17 - $56.44 $959,631 - $1.32 Million	23,309 New	23,309 $1.05 Million

Others Institutions Holding ANIP

# of Institutions

248

Shares Held

20.1M

Call Options Held

19.9K

Put Options Held

12.8K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.66B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.

Account

Martingale Asset Management L P Ani Pharmaceuticals Inc Transaction History